The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
Malignant gliomas are the most common malignant primary brain tumors and one of the most challenging forms of cancers to treat. Despite advances in conventional treatment, the outcome for patients remains almost universally fatal. This poor prognosis is due to therapeutic resistance and tumor recurr...
Main Authors: | Hongxiang Wang, Tao Xu, Ying Jiang, Hanchong Xu, Yong Yan, Da Fu, Juxiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558615000202 |
Similar Items
-
Promises of targeted therapy for low grade gliomas in children
by: E. F. Valiakhmetova, et al.
Published: (2019-07-01) -
CDC42—A promising immune-related target in glioma
by: Tao Jiang, et al.
Published: (2023-07-01) -
Oncolytic viral therapy as promising immunotherapy against glioma
by: Die Hu, et al.
Published: (2023-12-01) -
Photodynamic therapy of malignant brain gliomas
by: Volodymyr D. Rozumenko, et al.
Published: (2022-12-01) -
Regulated cell death in glioma: promising targets for natural small-molecule compounds
by: Mingyu Han, et al.
Published: (2024-01-01)